Regeneron Pharmaceuticals Inc REGN:NASDAQ

Last Price$289.32Cboe Real-Time Last Sale as of 2:24PM ET 8/23/19
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change-5.70(1.93%)
Bid (Size)$289.26 (13)
Ask (Size)$289.51 (18)
Day Low / High$288.00 - 296.26
Volume453.5 K
  • Latest Stories
  • Commentary and Analysis
Regeneron Pharmaceuticals Says Trial Shows Efficacy in Genetic Cholesterol Disorder Treatment
11:47AM ET 8/14/2019 MT Newswires

Regeneron Pharmaceuticals (REGN) said it achieved positive phase 3 trial results for evinacumab, a monoclonal antibody that specifically binds to...

Regeneron Pharma's EYLEA Injection Prefilled Syringe Gets Regulator Nod - Stock Up 3%
2:32PM ET 8/13/2019 MT Newswires

Regeneron Pharmaceuticals (REGN) said on Tuesday the US Food and Drug Administration has approved the Chemistry, Manufacturing and Controls Prior-Approval...

Regeneron Says REGN-EB3 Therapy Shows Superiority to ZMapp in Preventing Ebola Deaths
3:15PM ET 8/12/2019 MT Newswires

Regeneron Pharmaceuticals (REGN), a clinical stage biopharmaceutical company, said on Monday that a clinical trial evaluating four investigational...

Analysts' Scale Up Regeneron Pharmaceuticals' Q3, 2019, 2020 Earnings Estimates
8:01AM ET 8/09/2019 MT Newswires

Q3, 2019, and 2020`s earnings forecasts for Regeneron Pharmaceuticals Inc (NASDAQ:REGN, Recent Price: 309.87) have been scaled up. The Q3 earnings estimate...

Analysts' Scale Up Regeneron Pharmaceuticals' Q3, 2019, 2020 Earnings Estimates
5:41PM ET 8/08/2019 MT Newswires

Regeneron Pharmaceuticals Inc's (NASDAQ:REGN, Recent Price: 302.22) forecasted earnings estimates for Q3 ending September 30, 2019, and the expectations...

Analyst Actions: Baird Upgrades Regeneron Pharmaceuticals to Outperform From Neutral, Price Target $410
12:38PM ET 8/07/2019 MT Newswires

Regeneron Pharmaceuticals (REGN) has an average rating of hold, with an average price target of $393. Price: 301.47, Change: +1.21, Percent Change: +0.40...

--Analyst Actions: Regeneron Pharmaceuticals' PT Cut to $325 From $333 at Credit Suisse on Future Eylea Competition; Neutral Rating Reiterated
10:41AM ET 8/07/2019 MT Newswires

Price: 296.16, Change: -4.10, Percent Change: -1.37 ...

--Analyst Actions: RBC Lifts Price Target on Regeneron Pharmaceuticals to $399 From $396; Sector Perform Kept
9:23AM ET 8/07/2019 MT Newswires

Price: 301.10, Change: +0.84, Percent Change: +0.28 ...

Research Alert: CFRA Keeps Buy Opinion On Shares Of Regeneron Pharmaceuticals, Inc.
4:20PM ET 8/06/2019 MT Newswires

CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as...

Regeneron Pharmaceuticals Tops Q2 Non-GAAP EPS, Revenue Estimates
2:02PM ET 8/06/2019 MT Newswires

Regeneron Pharmaceuticals (REGN) said Tuesday hat its Q2 non-GAAP net income was $690 million, or $6.02 per diluted share, improving year over year from...